Global Injectable Viscosupplementation Market Research Report 2025

Industry: Medical Devices & Consumables

Published: 2025-01-13

Pages: 81 Pages

Report ld: 3490943

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Injectable Viscosupplementation was valued at US$ 1945 million in the year 2024 and is projected to reach a revised size of US$ 2483 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

Injectable Viscosupplementation Market Size(US$)

M= millions and B=billions

Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Viscosupplementation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Viscosupplementation.

The Injectable Viscosupplementation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Viscosupplementation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Viscosupplementation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Report Metric
Details
Report Title
Global Injectable Viscosupplementation Market Research Report 2025
Forecasted Market Size in 2031
US$ 2483 million
CAGR(2025-2031)
3.6%
Market Size Available for Years
2025-2031
Global Injectable Viscosupplementation Companies Covered
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Global Injectable Viscosupplementation Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Viscosupplementation Market, Segment by Type
Single Injection
Three Injection
Five Injection
Global Injectable Viscosupplementation Market, Segment by Application
Hospital
Clinic
Other
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Injectable Viscosupplementation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Injectable Viscosupplementation Market Overview
    1.1 Product Definition
    1.2 Injectable Viscosupplementation by Type
        1.2.1 Global Injectable Viscosupplementation Market Value Comparison by Type (2024 VS 2031)
        1.2.2 Single Injection
        1.2.3 Three Injection
        1.2.4 Five Injection
    1.3 Injectable Viscosupplementation by Application
        1.3.1 Global Injectable Viscosupplementation Market Value by Application (2024 VS 2031)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Global Injectable Viscosupplementation Market Size Estimates and Forecasts
        1.4.1 Global Injectable Viscosupplementation Revenue 2020-2031
        1.4.2 Global Injectable Viscosupplementation Sales 2020-2031
        1.4.3 Global Injectable Viscosupplementation Market Average Price (2020-2031)
    1.5 Assumptions and Limitations

2 Injectable Viscosupplementation Market Competition by Manufacturers
    2.1 Global Injectable Viscosupplementation Sales Market Share by Manufacturers (2020-2025)
    2.2 Global Injectable Viscosupplementation Revenue Market Share by Manufacturers (2020-2025)
    2.3 Global Injectable Viscosupplementation Average Price by Manufacturers (2020-2025)
    2.4 Global Key Players of Injectable Viscosupplementation, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Injectable Viscosupplementation, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Injectable Viscosupplementation, Product Type & Application
    2.7 Global Key Manufacturers of Injectable Viscosupplementation, Date of Enter into This Industry
    2.8 Global Injectable Viscosupplementation Market Competitive Situation and Trends
        2.8.1 Global Injectable Viscosupplementation Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Injectable Viscosupplementation Players Market Share by Revenue
        2.8.3 Global Injectable Viscosupplementation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Injectable Viscosupplementation Market Scenario by Region
    3.1 Global Injectable Viscosupplementation Market Size by Region: 2020 Versus 2024 Versus 2031
    3.2 Global Injectable Viscosupplementation Sales by Region: 2020-2031
        3.2.1 Global Injectable Viscosupplementation Sales by Region: 2020-2025
        3.2.2 Global Injectable Viscosupplementation Sales by Region: 2026-2031
    3.3 Global Injectable Viscosupplementation Revenue by Region: 2020-2031
        3.3.1 Global Injectable Viscosupplementation Revenue by Region: 2020-2025
        3.3.2 Global Injectable Viscosupplementation Revenue by Region: 2026-2031
    3.4 North America Injectable Viscosupplementation Market Facts & Figures by Country
        3.4.1 North America Injectable Viscosupplementation Market Size by Country: 2020 VS 2024 VS 2031
        3.4.2 North America Injectable Viscosupplementation Sales by Country (2020-2031)
        3.4.3 North America Injectable Viscosupplementation Revenue by Country (2020-2031)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Injectable Viscosupplementation Market Facts & Figures by Country
        3.5.1 Europe Injectable Viscosupplementation Market Size by Country: 2020 VS 2024 VS 2031
        3.5.2 Europe Injectable Viscosupplementation Sales by Country (2020-2031)
        3.5.3 Europe Injectable Viscosupplementation Revenue by Country (2020-2031)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Injectable Viscosupplementation Market Facts & Figures by Region
        3.6.1 Asia Pacific Injectable Viscosupplementation Market Size by Region: 2020 VS 2024 VS 2031
        3.6.2 Asia Pacific Injectable Viscosupplementation Sales by Region (2020-2031)
        3.6.3 Asia Pacific Injectable Viscosupplementation Revenue by Region (2020-2031)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Injectable Viscosupplementation Market Facts & Figures by Country
        3.7.1 Latin America Injectable Viscosupplementation Market Size by Country: 2020 VS 2024 VS 2031
        3.7.2 Latin America Injectable Viscosupplementation Sales by Country (2020-2031)
        3.7.3 Latin America Injectable Viscosupplementation Revenue by Country (2020-2031)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Injectable Viscosupplementation Market Facts & Figures by Country
        3.8.1 Middle East and Africa Injectable Viscosupplementation Market Size by Country: 2020 VS 2024 VS 2031
        3.8.2 Middle East and Africa Injectable Viscosupplementation Sales by Country (2020-2031)
        3.8.3 Middle East and Africa Injectable Viscosupplementation Revenue by Country (2020-2031)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

4 Segment by Type
    4.1 Global Injectable Viscosupplementation Sales by Type (2020-2031)
        4.1.1 Global Injectable Viscosupplementation Sales by Type (2020-2025)
        4.1.2 Global Injectable Viscosupplementation Sales by Type (2026-2031)
        4.1.3 Global Injectable Viscosupplementation Sales Market Share by Type (2020-2031)
    4.2 Global Injectable Viscosupplementation Revenue by Type (2020-2031)
        4.2.1 Global Injectable Viscosupplementation Revenue by Type (2020-2025)
        4.2.2 Global Injectable Viscosupplementation Revenue by Type (2026-2031)
        4.2.3 Global Injectable Viscosupplementation Revenue Market Share by Type (2020-2031)
    4.3 Global Injectable Viscosupplementation Price by Type (2020-2031)

5 Segment by Application
    5.1 Global Injectable Viscosupplementation Sales by Application (2020-2031)
        5.1.1 Global Injectable Viscosupplementation Sales by Application (2020-2025)
        5.1.2 Global Injectable Viscosupplementation Sales by Application (2026-2031)
        5.1.3 Global Injectable Viscosupplementation Sales Market Share by Application (2020-2031)
    5.2 Global Injectable Viscosupplementation Revenue by Application (2020-2031)
        5.2.1 Global Injectable Viscosupplementation Revenue by Application (2020-2025)
        5.2.2 Global Injectable Viscosupplementation Revenue by Application (2026-2031)
        5.2.3 Global Injectable Viscosupplementation Revenue Market Share by Application (2020-2031)
    5.3 Global Injectable Viscosupplementation Price by Application (2020-2031)

6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Company Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.1.4 Sanofi Injectable Viscosupplementation Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 Anika Therapeutics
        6.2.1 Anika Therapeutics Company Information
        6.2.2 Anika Therapeutics Description and Business Overview
        6.2.3 Anika Therapeutics Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.2.4 Anika Therapeutics Injectable Viscosupplementation Product Portfolio
        6.2.5 Anika Therapeutics Recent Developments/Updates
    6.3 Seikagaku
        6.3.1 Seikagaku Company Information
        6.3.2 Seikagaku Description and Business Overview
        6.3.3 Seikagaku Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.3.4 Seikagaku Injectable Viscosupplementation Product Portfolio
        6.3.5 Seikagaku Recent Developments/Updates
    6.4 Zimmer Biomet
        6.4.1 Zimmer Biomet Company Information
        6.4.2 Zimmer Biomet Description and Business Overview
        6.4.3 Zimmer Biomet Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.4.4 Zimmer Biomet Injectable Viscosupplementation Product Portfolio
        6.4.5 Zimmer Biomet Recent Developments/Updates
    6.5 Bioventus
        6.5.1 Bioventus Company Information
        6.5.2 Bioventus Description and Business Overview
        6.5.3 Bioventus Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.5.4 Bioventus Injectable Viscosupplementation Product Portfolio
        6.5.5 Bioventus Recent Developments/Updates
    6.6 Ferring
        6.6.1 Ferring Company Information
        6.6.2 Ferring Description and Business Overview
        6.6.3 Ferring Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.6.4 Ferring Injectable Viscosupplementation Product Portfolio
        6.6.5 Ferring Recent Developments/Updates
    6.7 LG Chem
        6.7.1 LG Chem Company Information
        6.7.2 LG Chem Description and Business Overview
        6.7.3 LG Chem Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.7.4 LG Chem Injectable Viscosupplementation Product Portfolio
        6.7.5 LG Chem Recent Developments/Updates
    6.8 Freda
        6.8.1 Freda Company Information
        6.8.2 Freda Description and Business Overview
        6.8.3 Freda Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.8.4 Freda Injectable Viscosupplementation Product Portfolio
        6.8.5 Freda Recent Developments/Updates
    6.9 Haohai Biological
        6.9.1 Haohai Biological Company Information
        6.9.2 Haohai Biological Description and Business Overview
        6.9.3 Haohai Biological Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.9.4 Haohai Biological Injectable Viscosupplementation Product Portfolio
        6.9.5 Haohai Biological Recent Developments/Updates
    6.10 Shanghai Jingfeng
        6.10.1 Shanghai Jingfeng Company Information
        6.10.2 Shanghai Jingfeng Description and Business Overview
        6.10.3 Shanghai Jingfeng Injectable Viscosupplementation Sales, Revenue and Gross Margin (2020-2025)
        6.10.4 Shanghai Jingfeng Injectable Viscosupplementation Product Portfolio
        6.10.5 Shanghai Jingfeng Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
    7.1 Injectable Viscosupplementation Industry Chain Analysis
    7.2 Injectable Viscosupplementation Raw Material Supply Analysis
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Injectable Viscosupplementation Production Mode & Process Analysis
    7.4 Injectable Viscosupplementation Sales and Marketing
        7.4.1 Injectable Viscosupplementation Sales Channels
        7.4.2 Injectable Viscosupplementation Distributors
    7.5 Injectable Viscosupplementation Customer Analysis

8 Injectable Viscosupplementation Market Dynamics
    8.1 Injectable Viscosupplementation Industry Trends
    8.2 Injectable Viscosupplementation Market Drivers
    8.3 Injectable Viscosupplementation Market Challenges
    8.4 Injectable Viscosupplementation Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Injectable Viscosupplementation Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Injectable Viscosupplementation Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Injectable Viscosupplementation Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Injectable Viscosupplementation Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Injectable Viscosupplementation Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Injectable Viscosupplementation Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Injectable Viscosupplementation Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Injectable Viscosupplementation Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Injectable Viscosupplementation, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Injectable Viscosupplementation, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Injectable Viscosupplementation, Product Type & Application
 Table 12. Global Key Manufacturers of Injectable Viscosupplementation, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Injectable Viscosupplementation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Viscosupplementation as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Injectable Viscosupplementation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Injectable Viscosupplementation Sales by Region (2020-2025) & (K Units)
 Table 18. Global Injectable Viscosupplementation Sales Market Share by Region (2020-2025)
 Table 19. Global Injectable Viscosupplementation Sales by Region (2026-2031) & (K Units)
 Table 20. Global Injectable Viscosupplementation Sales Market Share by Region (2026-2031)
 Table 21. Global Injectable Viscosupplementation Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Injectable Viscosupplementation Revenue Market Share by Region (2020-2025)
 Table 23. Global Injectable Viscosupplementation Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Injectable Viscosupplementation Revenue Market Share by Region (2026-2031)
 Table 25. North America Injectable Viscosupplementation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Injectable Viscosupplementation Sales by Country (2020-2025) & (K Units)
 Table 27. North America Injectable Viscosupplementation Sales by Country (2026-2031) & (K Units)
 Table 28. North America Injectable Viscosupplementation Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Injectable Viscosupplementation Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Injectable Viscosupplementation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Injectable Viscosupplementation Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Injectable Viscosupplementation Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Injectable Viscosupplementation Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Injectable Viscosupplementation Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Injectable Viscosupplementation Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Injectable Viscosupplementation Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Injectable Viscosupplementation Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Injectable Viscosupplementation Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Injectable Viscosupplementation Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Injectable Viscosupplementation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Injectable Viscosupplementation Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Injectable Viscosupplementation Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Injectable Viscosupplementation Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Injectable Viscosupplementation Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Injectable Viscosupplementation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Injectable Viscosupplementation Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Injectable Viscosupplementation Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Injectable Viscosupplementation Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Injectable Viscosupplementation Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Injectable Viscosupplementation Sales (K Units) by Type (2020-2025)
 Table 51. Global Injectable Viscosupplementation Sales (K Units) by Type (2026-2031)
 Table 52. Global Injectable Viscosupplementation Sales Market Share by Type (2020-2025)
 Table 53. Global Injectable Viscosupplementation Sales Market Share by Type (2026-2031)
 Table 54. Global Injectable Viscosupplementation Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Injectable Viscosupplementation Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Injectable Viscosupplementation Revenue Market Share by Type (2020-2025)
 Table 57. Global Injectable Viscosupplementation Revenue Market Share by Type (2026-2031)
 Table 58. Global Injectable Viscosupplementation Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Injectable Viscosupplementation Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Injectable Viscosupplementation Sales (K Units) by Application (2020-2025)
 Table 61. Global Injectable Viscosupplementation Sales (K Units) by Application (2026-2031)
 Table 62. Global Injectable Viscosupplementation Sales Market Share by Application (2020-2025)
 Table 63. Global Injectable Viscosupplementation Sales Market Share by Application (2026-2031)
 Table 64. Global Injectable Viscosupplementation Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Injectable Viscosupplementation Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Injectable Viscosupplementation Revenue Market Share by Application (2020-2025)
 Table 67. Global Injectable Viscosupplementation Revenue Market Share by Application (2026-2031)
 Table 68. Global Injectable Viscosupplementation Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Injectable Viscosupplementation Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Injectable Viscosupplementation Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Anika Therapeutics Company Information
 Table 76. Anika Therapeutics Description and Business Overview
 Table 77. Anika Therapeutics Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Anika Therapeutics Injectable Viscosupplementation Product
 Table 79. Anika Therapeutics Recent Developments/Updates
 Table 80. Seikagaku Company Information
 Table 81. Seikagaku Description and Business Overview
 Table 82. Seikagaku Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Seikagaku Injectable Viscosupplementation Product
 Table 84. Seikagaku Recent Developments/Updates
 Table 85. Zimmer Biomet Company Information
 Table 86. Zimmer Biomet Description and Business Overview
 Table 87. Zimmer Biomet Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Zimmer Biomet Injectable Viscosupplementation Product
 Table 89. Zimmer Biomet Recent Developments/Updates
 Table 90. Bioventus Company Information
 Table 91. Bioventus Description and Business Overview
 Table 92. Bioventus Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bioventus Injectable Viscosupplementation Product
 Table 94. Bioventus Recent Developments/Updates
 Table 95. Ferring Company Information
 Table 96. Ferring Description and Business Overview
 Table 97. Ferring Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Ferring Injectable Viscosupplementation Product
 Table 99. Ferring Recent Developments/Updates
 Table 100. LG Chem Company Information
 Table 101. LG Chem Description and Business Overview
 Table 102. LG Chem Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. LG Chem Injectable Viscosupplementation Product
 Table 104. LG Chem Recent Developments/Updates
 Table 105. Freda Company Information
 Table 106. Freda Description and Business Overview
 Table 107. Freda Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Freda Injectable Viscosupplementation Product
 Table 109. Freda Recent Developments/Updates
 Table 110. Haohai Biological Company Information
 Table 111. Haohai Biological Description and Business Overview
 Table 112. Haohai Biological Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Haohai Biological Injectable Viscosupplementation Product
 Table 114. Haohai Biological Recent Developments/Updates
 Table 115. Shanghai Jingfeng Company Information
 Table 116. Shanghai Jingfeng Description and Business Overview
 Table 117. Shanghai Jingfeng Injectable Viscosupplementation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai Jingfeng Injectable Viscosupplementation Product
 Table 119. Shanghai Jingfeng Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Injectable Viscosupplementation Distributors List
 Table 123. Injectable Viscosupplementation Customers List
 Table 124. Injectable Viscosupplementation Market Trends
 Table 125. Injectable Viscosupplementation Market Drivers
 Table 126. Injectable Viscosupplementation Market Challenges
 Table 127. Injectable Viscosupplementation Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Injectable Viscosupplementation
 Figure 2. Global Injectable Viscosupplementation Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Injectable Viscosupplementation Market Share by Type: 2024 & 2031
 Figure 4. Single Injection Product Picture
 Figure 5. Three Injection Product Picture
 Figure 6. Five Injection Product Picture
 Figure 7. Global Injectable Viscosupplementation Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Injectable Viscosupplementation Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Injectable Viscosupplementation Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Injectable Viscosupplementation Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Injectable Viscosupplementation Sales (2020-2031) & (K Units)
 Figure 15. Global Injectable Viscosupplementation Average Price (US$/Unit) & (2020-2031)
 Figure 16. Injectable Viscosupplementation Report Years Considered
 Figure 17. Injectable Viscosupplementation Sales Share by Manufacturers in 2024
 Figure 18. Global Injectable Viscosupplementation Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Injectable Viscosupplementation Players: Market Share by Revenue in Injectable Viscosupplementation in 2024
 Figure 20. Injectable Viscosupplementation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Injectable Viscosupplementation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Injectable Viscosupplementation Sales Market Share by Country (2020-2031)
 Figure 23. North America Injectable Viscosupplementation Revenue Market Share by Country (2020-2031)
 Figure 24. United States Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Injectable Viscosupplementation Sales Market Share by Country (2020-2031)
 Figure 27. Europe Injectable Viscosupplementation Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Injectable Viscosupplementation Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Injectable Viscosupplementation Revenue Market Share by Region (2020-2031)
 Figure 35. China Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Injectable Viscosupplementation Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Injectable Viscosupplementation Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Injectable Viscosupplementation Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Injectable Viscosupplementation Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Injectable Viscosupplementation Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Injectable Viscosupplementation by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Injectable Viscosupplementation by Type (2020-2031)
 Figure 56. Global Injectable Viscosupplementation Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Injectable Viscosupplementation by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Injectable Viscosupplementation by Application (2020-2031)
 Figure 59. Global Injectable Viscosupplementation Price (US$/Unit) by Application (2020-2031)
 Figure 60. Injectable Viscosupplementation Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description

The global market for Injectable Viscosupplementation was valued at US$ 1945 million in the year 2024 and is projected to reach a revised size of US$ 2483 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Viscosupplementation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Viscosupplementation.

The Injectable Viscosupplementation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Viscosupplementation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Viscosupplementation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Injectable Viscosupplementation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Related Reports

Global Injectable Viscosupplementation Market Research Report 2024
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
Published: 2024-01-18
Pages: 93
USD 2900.00
(Single User License)
Global Injectable Viscosupplementation Market Insights, Forecast to 2030
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
Published: 2024-04-15
Pages: 105
USD 4900.00
(Single User License)
Injectable Viscosupplementation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Viscosupplementation was estimated to be worth US$ 1945 million in 2024 and is forecast to a readjusted size of US$ 2483 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 109
USD 3950.00
(Single User License)
Global Injectable Viscosupplementation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Viscosupplementation market is projected to grow from US$ 1945 million in 2024 to US$ 2483 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 145
USD 4900.00
(Single User License)
Global Injectable Viscosupplementation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Viscosupplementation market size was US$ 1945 million in 2024 and is forecast to a readjusted size of US$ 2483 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Injectable Viscosupplementation Market Research Report 2026
The global Injectable Viscosupplementation market was valued at US$ 2008 million in 2025 and is anticipated to reach US$ 2563 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 112
USD 2900.00
(Single User License)
Injectable Viscosupplementation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Viscosupplementation was estimated to be worth US$ 2008 million in 2025 and is projected to reach US$ 2563 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)

Global Injectable Viscosupplementation Market Research Report 2024
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
Published: 2024-01-18
Pages: 93
USD 2900.00 (Single User License)
Global Injectable Viscosupplementation Market Insights, Forecast to 2030
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
Published: 2024-04-15
Pages: 105
USD 4900.00 (Single User License)
Injectable Viscosupplementation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Viscosupplementation was estimated to be worth US$ 1945 million in 2024 and is forecast to a readjusted size of US$ 2483 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 109
USD 3950.00 (Single User License)
Global Injectable Viscosupplementation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Viscosupplementation market is projected to grow from US$ 1945 million in 2024 to US$ 2483 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 145
USD 4900.00 (Single User License)
Global Injectable Viscosupplementation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Viscosupplementation market size was US$ 1945 million in 2024 and is forecast to a readjusted size of US$ 2483 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)
Global Injectable Viscosupplementation Market Research Report 2026
The global Injectable Viscosupplementation market was valued at US$ 2008 million in 2025 and is anticipated to reach US$ 2563 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 112
USD 2900.00 (Single User License)
Injectable Viscosupplementation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Viscosupplementation was estimated to be worth US$ 2008 million in 2025 and is projected to reach US$ 2563 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 128
USD 3950.00 (Single User License)